Benzinga··Business WirePaysign Surges 51% in Q1 as Patient Affordability Programs Fuel Pharma Growth
Paysign reported Q1 2026 revenue of $28.04M (+51% YoY), driven by pharma growth and patient affordability expansion. Net income doubled to $5.44M.
PAYSrevenue growthEBITDA